Generic versus brand-name North American topical glaucoma drops.

Area of Science:

• Ophthalmology
• Pharmaceutical Sciences
• Materials Science

Background:

• Glaucoma medication adherence is crucial for managing intraocular pressure.
• Generic drug substitution is common, but physical properties may vary.
• Understanding physical differences between branded and generic eye drops is essential for consistent therapeutic outcomes.

Purpose of the Study:

• To compare physical characteristics of brand-name glaucoma eye drops with their generic counterparts in North America.
• To assess differences in bottle design, viscosity, surface tension, and drop volume.

Main Methods:

• An experimental study analyzed 5 bottles each of 11 types of glaucoma eye drops.
• Drop volume was determined using density calculations and an analytic balance.
• Viscosity was measured via rotational rheometry.
• Bottle tip diameter and surface tension were also quantified.

Main Results:

• Significant variations were found in drop volume, viscosity, surface tension, and bottle tip size between brand-name Timoptic XE and its generics.
• Canadian Timoptic XE had 20x higher viscosity and 31% higher surface tension than its generic.
• American Timoptic XE showed 100x higher viscosity and 21% higher surface tension than its generic, with larger bottle tips.

Conclusions:

• Brand-name glaucoma eye drops (Timoptic XE) exhibit substantial physical differences from their generic equivalents.
• These variations in drop characteristics and bottle design necessitate careful consideration for generic ophthalmic product interchangeability.
• Further evaluation of viscosity and bottle design is recommended for generic drug market entry.